Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "CIRC"

238 News Found

Qdenga approved in Indonesia for use regardless of prior dengue exposure
Drug Approval | August 28, 2022

Qdenga approved in Indonesia for use regardless of prior dengue exposure

Indonesia national agency for drug and food control, BPOM, approved QDENGA for use in individuals 6 to 45 years of age


USFDA grants emergency use authorization for Novavax COVID-19 vaccine
Drug Approval | August 22, 2022

USFDA grants emergency use authorization for Novavax COVID-19 vaccine

Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.


Godrej reveals how to win the war against Malaria through strategic collaboration
Public Health | August 20, 2022

Godrej reveals how to win the war against Malaria through strategic collaboration

~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership


Merck and Orna Therapeutics collaborate to advance Orna’s nextgen RNA technology
Biotech | August 17, 2022

Merck and Orna Therapeutics collaborate to advance Orna’s nextgen RNA technology

Collaboration supports multiple discovery efforts, including vaccines


Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
News | July 18, 2022

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’

Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru


SRL Diagnostics launches fatty liver index
Clinical Trials | July 13, 2022

SRL Diagnostics launches fatty liver index

An algorithm based testing for Fatty Liver Disease


Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7
News | July 12, 2022

Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7

The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds


Novavax aims COVID vaccine on Omicron in Q4
Drug Approval | July 05, 2022

Novavax aims COVID vaccine on Omicron in Q4

The vaccine is under FDA review


GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
People | June 17, 2022

GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer

Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics


Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants
News | June 14, 2022

Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants

Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile